IPO - Olema Pharmaceuticals, Inc.

Back to List of IPO Filings

Form Type: 424B5

Filing Date: 2025-01-15

Corporate Action: Ipo

Type: New

Accession Number: 000119312525007090

Filing Summary: Olema Pharmaceuticals, Inc. has filed a prospectus related to the offering of up to $150,000,000 in common stock through a sales agreement with TD Securities (USA) LLC. The shares offered will be at market prices over time. This agreement replaces a prior sales agreement with Cowen and Company. As of January 3, 2025, the last reported sale price of the common stock was $5.89 per share. Dating back to September 30, 2024, approximately 57,288,319 shares were outstanding, and after this offering, the total could rise to 82,755,212 shares, assuming maximum shares are sold. The proceeds from this offering will be used for general corporate purposes, including R&D and working capital. Investing in these securities carries risks which are detailed in the risk factors section of the prospectus.

Document Link: View Document

Additional details:

Common Stock Offered: Up to $150,000,000

Offering Price Per Share: $5.89

Agents Name: TD Securities (USA) LLC

Total Shares Post Offering: Up to 82,755,212

Principal Office Address: 780 Brannan Street, San Francisco, California 94103

Risk Factor Summary: Investing in common stock involves significant risk that may impact business performance and financial health.

Use Of Proceeds: For general corporate purposes, including research and development and working capital.

Comments

No comments yet. Be the first to comment!